Anal Cancer Clinical Trials

Find Anal Cancer Clinical Trials Near You

Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Device, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to examine the feasibility of adding pre-rehabilitation pelvic health physical therapy to standard of care radiation therapy treatment plan for female patients who have been diagnosed with cervical, vaginal, vulvar, uterine, or anal cancer and are a candidate for curative pelvic radiation with external beam. Participants will receive education on using a vaginal dilator for use during treatment and complete questionnaires looking at pain and sexual function.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

⁃ Female

⁃ ≥ 18 years old at the time of informed consent

⁃ Ability to provide written informed consent and HIPAA authorization

⁃ Primary diagnosis of cervical, vaginal, vulvar, uterine, or anal cancer

⁃ Candidate for curative pelvic radiation with external beam, with or without brachytherapy, per radiation oncologist's discretion

‣ Notes:

• Can have prior and/or current modalities of treatment to address diagnosis including surgery and chemotherapy

• Can receive radiation at any facility provided patient is able to perform Physical Therapy visits at IUH North/Schwarz Cancer Center

Locations
United States
Indiana
IU Health West
RECRUITING
Avon
IU Health Schwarz Cancer Center
RECRUITING
Carmel
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
RECRUITING
Indianapolis
Contact Information
Primary
Namita Agrawal, MD
agrawaln@indiana.edu
(317)944-2524
Backup
Sarah Dutkevich, RN
sdutkevi@iu.edu
(317)278-5618
Time Frame
Start Date: 2024-01-16
Estimated Completion Date: 2027-06
Participants
Target number of participants: 20
Treatments
Experimental: Pelvic health Assessment and Intervention
Related Therapeutic Areas
Sponsors
Leads: Indiana University

This content was sourced from clinicaltrials.gov